Genetic Medicines Company Passage Bio To Make U.S. Trading Debut On Feb.28

The Philadelphia-based Passage Bio is slated to debut on the Nasdaq Global Market under the symbol "PASG" on February 28, 2020.

from RTT - Biotech https://ift.tt/2SRFGDL
via IFTTT